Literature DB >> 24174125

Terson syndrome in conjunction with ruptured intracranial aneurysm and penetrating intracranial injury: a review of two cases.

Matt Rheinboldt1, Kirenza Francis, David Parrish, Derrick Harper, John Blase.   

Abstract

Terson syndrome, the presence of intraocular hemorrhage in the setting of acutely elevated intracranial pressure, was historically described in conjunction with acute subarachnoid hemorrhage; however, more recently, it has been associated with a gamut of intracranial pathophysiology ranging from blunt or penetrating injury to neurosurgical procedures. We describe two cases of profound intracranial injury, secondary to ballistic injury, and a ruptured intracranial aneurysm, in which posterior chamber ocular hemorrhage was noted on CT imaging. Though the outcome in such cases, as with ours, is often poor, the findings are germane to clinical care as the presence of Terson syndrome has been noted to be a negative prognostic factor in multiple clinical reviews. Additionally, clinical recovery can be impacted adversely by lasting visual deficits or retinal degradation in the absence of timely ophthalmologic intervention.

Entities:  

Mesh:

Year:  2013        PMID: 24174125     DOI: 10.1007/s10140-013-1172-2

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  11 in total

1.  Screening for ocular hemorrhages in patients with ruptured cerebral aneurysms: a prospective study of 99 patients.

Authors:  R T Frizzell; F Kuhn; R Morris; C Quinn; W S Fisher
Journal:  Neurosurgery       Date:  1997-09       Impact factor: 4.654

2.  Teaching NeuroImages: Terson syndrome in cortical venous sinus thrombosis.

Authors:  Aastha Takkar; Praveen Kesav; Vivek Lal; Amod Gupta
Journal:  Neurology       Date:  2013-08-06       Impact factor: 9.910

3.  Terson syndrome: CT evaluation in 12 patients.

Authors:  C E Swallow; J S Tsuruda; K B Digre; M J Glaser; H C Davidson; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  1998-04       Impact factor: 3.825

4.  Terson haemorrhage in patients suffering aneurysmal subarachnoid haemorrhage: a prospective analysis of 60 consecutive patients.

Authors:  Martin N Stienen; Sebastian Lücke; Oliver P Gautschi; Albrecht Harders
Journal:  Clin Neurol Neurosurg       Date:  2012-04-01       Impact factor: 1.876

5.  Terson's syndrome: a reversible cause of blindness following subarachnoid hemorrhage.

Authors:  A M Garfinkle; I R Danys; D A Nicolle; A R Colohan; S Brem
Journal:  J Neurosurg       Date:  1992-05       Impact factor: 5.115

6.  Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage.

Authors:  F Kuhn; R Morris; C D Witherspoon; V Mester
Journal:  Ophthalmology       Date:  1998-03       Impact factor: 12.079

7.  Terson's syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients.

Authors:  B Pfausler; R Belcl; R Metzler; I Mohsenipour; E Schmutzhard
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

8.  Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage.

Authors:  T Ogawa; T Kitaoka; Y Dake; T Amemiya
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

9.  Bilateral retinal hemorrhage after endoscopic third ventriculostomy: iatrogenic Terson syndrome.

Authors:  Eelco W Hoving; Mehrnoush Rahmani; Leonie I Los; Victor W Renardel de Lavalette
Journal:  J Neurosurg       Date:  2009-05       Impact factor: 5.115

10.  Terson syndrome caused by intraventricular hemorrhage associated with moyamoya disease.

Authors:  Ho Sang Kim; Sang Weon Lee; Soon Ki Sung; Eui Kyo Seo
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30
View more
  2 in total

Review 1.  A systematic approach to CT evaluation of orbital trauma.

Authors:  Aaron M Betts; William T O'Brien; Brett W Davies; Omaya H Youssef
Journal:  Emerg Radiol       Date:  2014-04-23

2.  25G compared with 20G vitrectomy under Resight non-contact wide-angle lenses for Terson syndrome.

Authors:  Xinbang Mao; Zhipeng You
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.